Skip to content

Effect of propolis on joint pain

Analysis of the therapeutic effect of propolis in patients with joint pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6ts54x
Enrollment
Unknown
Registered
2020-02-17
Start date
2019-06-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

The research intervention consists of the use of an ethanol extract of red propolis from Alagoas, orally, in the amount of 1mL, once a day, for 30 days. This research also has a control group, which w
Biological/vaccine
Dietary supplement
Other
E02.190
V03.175.250

Sponsors

Pós Graduação em Ciências da Saúde
Lead Sponsor
Pós Graduação em Ciências da Saúde
Collaborator

Eligibility

Age
40 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients with clinical diagnosis of joint pain due to inflammation in the intra and / or peri-articular structures by a doctor and presence of pain caused by the disease mentioned during the initial evaluation, of both sexes and any ethnic group will be included in the study.

Exclusion criteria

Exclusion criteria: Exclusion criteria are: pregnant patients with a history of bee sting allergy and other therapies; hx of gastrointestinal bleeding, gastric perforation; kidney disease, liver disease; current history of alcoholism; use of anticoagulants; prosthetic implants or pacemaker; serious uncontrolled chronic diseases (high blood pressure, diabetes mellitus, heart disease and other diseases that, by their nature or by the proposed treatment, may interfere with the proposed assessment). Individuals who make use of various pharmacological therapies will be evaluated professional pharmaceutical pain able to understand possible pharmacological interactions, deciding for the insertion or exclusion of this individual in the current research.

Design outcomes

Primary

MeasureTime frame
Reduction of pain intensity related to underlying pathology according to the visual pain scale, with an expected reduction of 2 points in the intensity of the scale used.

Secondary

MeasureTime frame
Improvement of joint function, verified by measuring the range of motion and muscle strength, with an increase of at least 10º in the range of articular movement verified by goniometry.;Improved functionality with reduced indexes in the Lequesne functional questionnaire, reducing the degree of functional impairment by one level.;Maintenance of biochemical parameters, without changes in blood count, renal and hepatic profile, analyzed using biochemical analysis devices.

Countries

Brazil

Contacts

Public ContactCamila Sales

Pós Graduação em Ciências da Saúde

camila.mourasales@gmail.com+55(82)999297656

Outcome results

None listed

Source: REBEC (via WHO ICTRP)